Kingsley Taft is a senior partner and national co-chair of Goodwin's Life Sciences Practice. He represents emerging to mature life sciences companies in all aspects of their business and legal affairs, including company formation, venture financings, strategic alliances, M&A, IPOs and other financing transactions. Mr. Taft has extensive experience in assisting clients with JVs, strategic alliances and collaborations.
Mr. Taft has been recognized as a leading life sciences attorney by numerous legal guides. He has been annually ranked for more than a decade in Chambers USA: America’s Leading Lawyers for Business (Nationwide, Life Sciences: Corporate/Commercial – Band 1). Mr. Taft was inducted into the LMG Life Sciences Hall of Fame, an honor recognizing only a handful of attorneys for their industry contributions.
Before attending Harvard Law School, Mr. Taft earned a B.S in Chemistry from Yale University and a Ph.D. in Chemistry from the Massachusetts Institute of Technology.
Mr. Taft regularly serves as outside general counsel to biotechnology, pharmaceutical, medical device and medtech companies, closely advising management and directors as these companies raise capital, in-license and acquire IP and other assets, and then partner their technology, all with a view towards growth and liquidity. He also represents life science investors in connection with their portfolio investments.
Mr. Taft has been recognized by numerous legal guides for legal and life sciences industry expertise. In addition to the two listings noted above, Mr. Taft has also been named as a leading business lawyer by U.S. News-Best Lawyers (Biotechnology Law), LMG Life Sciences (Life Sciences Star), The Legal 500 United States (Healthcare: Life Sciences and Venture Capital and Emerging Companies), PLC Cross-border Life Sciences Handbook (Commercial and Partnering), IAM Patent 1000 (Licensing) and The International Who’s Who of Life Sciences Lawyers (Transactional).
Under his leadership, Goodwin’s Life Sciences Practice has received numerous awards and honors, including U.S. News’ Biotechnology Law Firm of the Year three years running (2013-2015), and perennial nationwide recognition by Chambers USA.